Bludigo

Active Ingredient(s): Indigotindisulfonate Sodium
FDA Approved: * July 8, 2022
Pharm Company: * PROVEPHARM SAS
Category: Diagnostic Aid
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bludigo 8 mg/ml Intravenous Injection
NDC: 81284-315
Labeler:
Provepharm Inc.